Latest Breaking News On - Lisa ricciardi - Page 1 : comparemela.com

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease

PURCHASE - Cognition Therapeutics, Inc., , a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual KOL event hosted on April 12, 2024.

Noord hollandAnton porsteinssonJort vijverbergMike moyerCasey mcdonaldMartinj sadowskiLisa ricciardiCompany or cognitionSecurities exchange commissionCognition therapeutics incAlzheimer center amsterdamUniversity of rochester alzheimer disease careSchool of medicineEducation programRochester alzheimerDisease care

Navigating Growth In Biotech A First-Person Insight

Navigating Growth In Biotech A First-Person Insight
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.

Lisa ricciardiRicciardi lisaScientific communityBiotech valuation and partnership opportunitiesBuilding trust and engagementCognition therapeuticsQuality scienceBedrock of biotech valuation and partnershipTarget engagementDemonstrating realLitmus test forWith the scientific communityBuilding trust and

Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference

Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Lisa ricciardiMike moyerCasey mcdonaldCognition therapeutics incCompany or cognitionTiberend strategic advisors incSecurities exchange commissionAnnual needham virtual healthcare conferenceCognition therapeuticsPrivate securities litigation reform actExchange commissionStrategic advisors

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript

Operator: Hello, everyone, and welcome to Cognition Therapeutics Fourth Quarter 2023 Earnings Call. Please note that this call is being recorded.

Mike moyerJay olsonLisa ricciardiCharles duncanTony caggianoJohn doyleJim galvinUniversity of miami school medicineLewy body dementia associationCantor fitzgeraldAlzheimer association international conferenceAlzheimer clinical trial consortiumCognition therapeutics incCognition therapeuticsCall transcript marchCognition therapeutics fourth quarter

Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update

Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Casey mcdonaldLisa ricciardiMike moyerJohn doyleInternational journal of molecular scienceSecurities exchange commissionCompany phaseCognition therapeutics incCompany or cognitionTiberend strategic advisors incMild to moderate alzheimerReport topline resultsRaise extends cash runway through mayConference call scheduled todayClinical highlightsClinical trials